The US Court of Appeals for the Eighth Circuit agreed with the Pharmaceutical Care Management Association that the Employee Retirement Income Security Act overturns an Iowa law that severely limited pharmacy benefit managers' use of Maximum Allowable Costs (MAC) lists to reduce costs for employers and consumers. The ruling is a "shot across the bow" for other states that might be considering adopting similar laws and "sends an important signal that states can't impose a patchwork of costly mandates on employers and unions that offer pharmacy benefits," said PCMA President and CEO Mark Merritt.
CVS Health will offer Impax Impax Laboratories' Adrenaclick epinephrine injection for $109.99 per two-pack before potential discounts, compared with an initial list price of $300 for Mylan's generic version of its own EpiPen.
The Senate set the stage for unraveling the Affordable Care Act in a 51-48 vote that orders key panels to develop legislation by Jan. 27 that would repeal the law. The House is expected to vote on the measure Friday.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications